4//SEC Filing
JOHNSON KENNETH ERLAND 4
Accession 0001867096-25-000013
CIK 0001867096other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:42 PM ET
Size
5.1 KB
Accession
0001867096-25-000013
Insider Transaction Report
Form 4
JOHNSON KENNETH ERLAND
See Remarks
Transactions
- Tax Payment
Common Stock
2025-01-03$3.61/sh−12,401$44,768→ 361,764 total
Footnotes (2)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of Restricted Stock Units vested as of January 3, 2025.
- [F2]Includes 1,129 shares acquired on December 31, 2024 under the Xeris Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan, as amended.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001743774
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:42 PM ET
- Size
- 5.1 KB